Ovulation can be stimulated through lifestyle changes, oral medications, injectable hormones, or a combination of these approaches. The right method depends on why ovulation isn’t happening. For most people, treatment starts with the least invasive options and escalates only if needed.
Why Ovulation Stops or Becomes Irregular
Ovulation fails when the hormonal chain reaction that matures and releases an egg gets disrupted. The most common cause is polycystic ovary syndrome (PCOS), which affects hormone signaling and is closely tied to insulin resistance. Other causes include being significantly underweight or overweight, thyroid disorders, high prolactin levels, and a condition called hypothalamic amenorrhea, where stress, extreme exercise, or low body weight shuts down reproductive hormone production at the brain level.
Identifying the underlying cause matters because it determines which stimulation method will work. A person with PCOS and insulin resistance needs a different approach than someone whose brain simply isn’t sending the right hormonal signals to the ovaries.
Dietary Changes That Protect Ovulation
What you eat has a surprisingly large effect on whether you ovulate. In a major cohort study tracking thousands of women, those who followed a pattern researchers called a “fertility diet” had a 66% lower risk of anovulatory infertility compared to those with the least adherence. This eating pattern emphasizes plant protein over animal protein, monounsaturated fats, low-glycemic carbohydrates, high-fat dairy, and iron-rich foods.
The specifics are striking. Women with the highest glycemic load in their diets (meaning lots of refined carbs that spike blood sugar) had a 92% higher risk of ovulation problems than women with the lowest glycemic load. Replacing just 5% of calories from animal protein with plant protein cut the risk of anovulatory infertility by more than 50%. Adding one daily serving of full-fat milk, without increasing total calories, reduced the risk by over 50% as well.
Trans fats are particularly harmful. Replacing just 2% of calories from other fat sources with trans fats doubled the risk of anovulatory infertility. Meanwhile, increasing fiber intake by 10 grams per day was linked to a 44% lower risk of ovulation disorders in women over 32. Consuming 700 micrograms of folic acid daily reduced the risk by 40 to 50%.
Weight Loss and Insulin Management
For people with PCOS who are overweight, losing as little as 5% of body weight can lead to significant improvement in ovulation. That’s roughly 8 to 10 pounds for someone who weighs 170. This works because excess body fat fuels insulin resistance, which in turn drives the hormonal imbalances that prevent ovulation.
When insulin resistance is a factor, an insulin-sensitizing medication can help restore ovulation. This type of drug lowers insulin levels, which reduces the excess androgen production that blocks egg development. A Cochrane review found that adding an insulin sensitizer to injectable hormone treatment roughly doubled the odds of a live birth compared to injectable hormones alone. If the baseline chance of a live birth with hormones alone was 27%, adding the insulin sensitizer pushed that chance to somewhere between 32% and 60%.
Inositol Supplements
Inositol is a naturally occurring compound that improves how cells respond to insulin. For women with PCOS undergoing fertility treatment, 2 grams of myo-inositol daily has been shown to improve egg quality and conception outcomes. Studies also suggest that combining myo-inositol with d-chiro-inositol at a 40:1 ratio (1 gram of myo-inositol to about 27.6 milligrams of d-chiro-inositol) produced higher pregnancy rates than myo-inositol alone. The typical dose is 2 grams per day, split across two or three doses.
Oral Medications for Ovulation Induction
When lifestyle changes aren’t enough, oral medications are the standard first step. Two drugs dominate this space, and both are taken for five consecutive days early in the menstrual cycle.
The first, clomiphene, works by tricking the brain into producing more follicle-stimulating hormone (FSH). The pituitary gland ramps up FSH output, which pushes one or more follicles in the ovary to grow. As the follicle matures, rising estrogen levels eventually trigger a surge of luteinizing hormone (LH), causing the egg to release. Clomiphene induces ovulation in about 80% of cycles in women who aren’t ovulating on their own. Of those who ovulate, 10 to 15% conceive per cycle, and 70 to 75% conceive within six to nine cycles of treatment.
The second option, letrozole, works differently but achieves a similar result. It blocks estrogen production, which causes the brain to compensate by increasing FSH. Pregnancy rates are comparable to clomiphene overall, but letrozole performs better for women with PCOS, which is why it’s now considered the first-line medication for that group.
Injectable Hormones
If oral medications don’t produce results, the next step is injectable gonadotropins. These are synthetic versions of FSH (and sometimes LH) delivered directly into the body, bypassing the brain entirely and stimulating the ovaries more aggressively. They’re used when oral medications have failed or when the brain itself isn’t producing adequate reproductive hormones.
Treatment typically starts at a low dose and increases gradually over the course of a cycle. If no follicle larger than 10 millimeters has developed after about seven days, the dose is nudged upward in small increments. This cautious “low and slow” approach is deliberate: injectable hormones carry a higher risk of stimulating too many follicles at once, which increases the chance of multiple pregnancy and a condition called ovarian hyperstimulation syndrome.
Monitoring During Stimulation
Any medicated ovulation cycle requires monitoring, usually with transvaginal ultrasound every one to three days. After five to seven days of medication, follicles in the ovaries start growing and typically reach about 10 millimeters. Monitoring continues until one or more leading follicles reach 16 to 22 millimeters, with at least one ideally hitting 18 millimeters or larger. At that point, you’re close to ovulation.
Monitoring serves two purposes: confirming that follicles are responding to treatment, and making sure too many aren’t growing at once. If ultrasound shows an excessive number of mature follicles, a cycle may be canceled to avoid high-order multiple pregnancies.
The Trigger Shot
Once follicles reach the target size of 16 to 22 millimeters, many treatment protocols use an injection of human chorionic gonadotropin (hCG) to trigger the final maturation and release of the egg. This “trigger shot” mimics the natural LH surge that causes ovulation. The egg is released approximately 36 hours after the injection, which allows precise timing of intercourse or insemination.
Risks of Ovarian Stimulation
The most significant risk of pharmacological ovulation stimulation is ovarian hyperstimulation syndrome (OHSS). This happens when the ovaries overreact to hormonal stimulation and become swollen and painful. In mild cases, you’ll feel bloating, mild nausea, and some abdominal discomfort, and symptoms resolve on their own with your next period. Moderate cases involve fluid buildup in the abdomen visible on ultrasound. Severe cases can cause difficulty breathing, rapid weight gain of more than a kilogram in 24 hours, very low urine output, and blood clotting complications.
OHSS is classified by timing as well as severity. Early-onset symptoms appear four to seven days after a trigger shot and usually resolve with menstruation. Late-onset OHSS begins at least nine days after the trigger, typically in response to a rising pregnancy hormone, tends to be more severe, and lasts longer. Injectable hormones carry a higher OHSS risk than oral medications, and the trigger shot itself is a key contributing factor. Warning signs to watch for include rapidly increasing abdominal girth, sudden weight gain, reduced urination, and shortness of breath.